HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3,3',4,4',5,5'-hexahydroxystilbene

Also Known As:

3,3',4,4',5,5'-hexahydroxy-trans-stilbene

Networked: 7 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Pyrogallol: 83
        3,3',4,4',5,5'-hexahydroxystilbene: 7
        Benzylidene Compounds: 10
        Stilbenes: 657
        3,3',4,4',5,5'-hexahydroxystilbene: 7

Experts

1.	Szekeres, Thomas: 4 articles (06/2010 - 09/2006)
2.	Jäger, Walter: 3 articles (02/2014 - 08/2008)
3.	Murias, Marek: 3 articles (02/2014 - 10/2006)
4.	Wierzchowski, Marcin: 2 articles (02/2014 - 11/2013)
5.	Erker, Thomas: 2 articles (10/2006 - 09/2006)
6.	Handler, Norbert: 2 articles (10/2006 - 09/2006)
7.	Saiko, Philipp: 2 articles (10/2006 - 09/2006)
8.	Dudka, Jaroslaw: 1 article (02/2014)
9.	Ksiazek, Krzysztof: 1 article (02/2014)
10.	Kucinska, Malgorzata: 1 article (02/2014)

Related Diseases

1.	Neoplasms (Cancer) 11/14/2013 - "3,3',4,4',5,5'-Hexahydroxy-trans-stilbene (M8) is a synthetic resveratrol derivative, advertised as a candidate drug highly effective against numerous malignancies. "
2.	Leukemia 10/01/2006 - "In the present study, the activity of a novel RV analog, 3,3',4,4',5,5'-hexahydroxystilbene (M8), was investigated in HL-60 human promyelocytic leukemia cells. " 01/01/2006 - "In this study, the activity of 3,3',4,4',5,5'-hexahydroxystilbene (M8) was investigated in HL-60 human promyelocytic leukemia cells. " 01/01/2006 - "Antitumor effects of 3,3',4,4',5,5'-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells." 10/01/2006 - "Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells." 09/01/2006 - "Antioxidant activity of resveratrol, piceatannol and 3,3',4,4',5,5'-hexahydroxy-trans-stilbene in three leukemia cell lines."
3.	T-Cell Leukemia (Leukemia, T Cell) 02/25/2014 - "In present study the effects of resveratrol (Res) and its three derivatives: 3,3',4,4'-tetrahydroxy-trans-stilbene (M6), 3,4,4',5-tetrahydroxy-trans-stilbene (M8) and 3,3',4,4',5,5'-hexahydroxy-trans-stilbene (M12) were investigated on T cell leukemia Jurkat cells. "
4.	Breast Neoplasms (Breast Cancer) 08/01/2008 - "In this study, the activity of 3,3',4,4',5,5'-hexahydroxystilbene (M8) was investigated in ZR-75-1, MDA-MB-231 and T47D human breast cancer cells. " 08/01/2008 - "Cytotoxic activity of 3,3',4,4',5,5'-hexahydroxystilbene against breast cancer cells is mediated by induction of p53 and downregulation of mitochondrial superoxide dismutase."
5.	Melanoma (Melanoma, Malignant) 06/01/2010 - "3,3',4,4',5,5'-hexahydroxystilbene impairs melanoma progression in a metastatic mouse model."

Related Drugs and Biologics

1.	Resveratrol
2.	3,3',4,4'-tetrahydroxystilbene
3.	Superoxide Dismutase
4.	Antioxidants
5.	3,3',4,5'-tetrahydroxystilbene